Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150
These Analysts Increase Their Forecasts On Hinge Health After Better-Than-Expected Q3 Results
Loading...